Skip to content

Efficacy and safety of repetitive transcranial magnetic stimulation in the treatment of benign epilepsy with centro-temporal spikes in children

Efficacy and safety of repetitive transcranial magnetic stimulation in the treatment of benign epilepsy with centro-temporal spikes in children

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047123
Enrollment
Unknown
Registered
2021-06-08
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign epilepsy of childhood with centro-temporal spikes (BECTS)

Interventions

1 group:rTMS stimulus
2 group:Sham stimulation

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1.Aged 5 to 14 years; 2.It meets the diagnostic criteria of benign epilepsy with centro-temporal spikes in children; 3.Imaging examination showed no obvious abnormality; 4.No cardio pulmonary abdominal diseases or nervous system diseases; 5.Agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.There is a mental illness and can't have relevant examination as required; 2.Cognitive impairment, IQ < 50; 3.There are metal implants in the body; 4.Previous intrauterine distress, dystocia, cerebral hemorrhage, etc.; 5.Patients who cannot complete the examination due to objective reasons; 6.After evaluation, there are any other reasons not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Discharge index during sleep;

Secondary

MeasureTime frame
Behavioral change;Seizure frequency;

Countries

China

Contacts

Public ContactRen Liankun

Xuanwu Hospital, Capital Medical University

rlkbrain2000@yahoo.com+86 13681576621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026